amiodarone has been researched along with verapamil in 203 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 87 (42.86) | 18.7374 |
| 1990's | 37 (18.23) | 18.2507 |
| 2000's | 53 (26.11) | 29.6817 |
| 2010's | 20 (9.85) | 24.3611 |
| 2020's | 6 (2.96) | 2.80 |
| Authors | Studies |
|---|---|
| Daugan, A; Dodic, N; Dumaitre, B; Pianetti, P | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Bakken, GA; Jurs, PC | 1 |
| Arieff, Z; Bardien-Kruger, S; Brink, P; Chandy, KG; Corfield, V; Wulff, H | 1 |
| Pajeva, IK; Wiese, M | 1 |
| Keserü, GM | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Cianchetta, G; Cruciani, G; Fravolini, A; Giesing, D; Singleton, RW; Vaz, RJ; Wildgoose, M; Zhang, M | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Cai, W; Hao, Y; Hu, P; Ma, D; Pan, H; Xie, X; Yu, AD; Yu, J; Yuan, J; Zhang, L; Zhu, H | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Jia, L; Sun, H | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Sen, S; Sinha, N | 1 |
| Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Freiwald, S; Jiang, Y; Jones, JP; Kaspera, R; Katayama, J; Lee, CA; Smith, E; Totah, RA; Walker, GS | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jewitt, DE | 2 |
| Theisen, K | 1 |
| Donaldson, RM | 1 |
| Brochier, M; Fauchier, JP | 1 |
| Curry, PV; Krikler, DM; Rowland, E | 1 |
| Coumel, P; Krikler, D; Rosen, MR; Wellens, HJ; Zipes, DP | 1 |
| Basiez, M; Labrid, C; Leinot, M; Talvard, J | 1 |
| Vaughan-Williams, EM | 1 |
| Troup, PJ; Zipes, DP | 1 |
| De'Thomatis, M; Falciola, N; Gallesio, R | 1 |
| Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
| Gronda, M; Rognoni, G; Rossi, P | 1 |
| Kaufmann, G | 1 |
| Brita, G; Caputi, AP; Chieppa, S; Coscia, L; Marmo, E; Rossi, F | 1 |
| Desaiah, D; Kodavanti, PR; Pentyala, SN; Yallapragada, PR | 1 |
| Denisiuk, VI; Kotsuta, GI; Lipnitskiĭ, TN; Osiadlaia, ES; Pilipchuk, VP; Stepaniuk, AV | 1 |
| Fomina, IG; Iankin, VV | 1 |
| Hohnloser, S; Just, H; Meinertz, T; Müller, B; Zehender, M | 1 |
| Ashavaid, TF; Colvin, RA; Katz, AM; Messineo, FC | 1 |
| Shpektor, AV; Susliak, NN | 1 |
| Boesch, D; Loor, F; Pourtier-Manzanedo, A | 1 |
| Boesch, D; Loor, F; Muller, K; Pourtier-Manzanedo, A | 1 |
| Mazur, NA; Shestakova, NV | 1 |
| Bettini, R; Cozzi, F; Dal Forno, P; Furlanello, F | 1 |
| Singh, BN; Takanaka, C | 1 |
| Horvat, M; Noc, M; Stajer, D | 1 |
| Aomine, M | 1 |
| Bandyopadhyay, S; Klaunig, JE; Somani, P | 1 |
| Clausse, B; Couvreur, P; Kubiak, C; Manil, L | 1 |
| Bechi, S; Cordoni, M; Franchini, C; Mazza, F; Micheli, G; Scalzini, A | 1 |
| Arriagada, C; Fajuri, A; González, R; Marchesse, M; Serrat, H | 1 |
| Kleinebenne, A; McKenna, WJ | 1 |
| Bald, R; Gembruch, U; Hansmann, M; Manz, M; Nitsch, J; Redel, DA; Rüddel, H; Schlebusch, H | 1 |
| Somberg, J | 1 |
| Anderson, JL | 1 |
| Broustet, JP; Douard, H; Mora, B | 1 |
| Bayés de Luna, A; Guindo, J; Oter, MC | 1 |
| Chittolini, L; Cozzi, E; Ghiringhelli, S; Glisenti, F; Straneo, G; Straneo, U; Tsialtas, D | 1 |
| Hwang, TF; Murthy, VS | 1 |
| Andersson, KE; Wettrell, G | 1 |
| Morganroth, J; Nestico, PF | 1 |
| Huang, SK; Marcus, FI | 1 |
| Campbell, RW; Wren, C | 1 |
| Agmon, J; Bassevich, R; Klainman, E; Rechavia, E; Sagie, A; Sclarovsky, S | 1 |
| Chauffert, B; Coudert, B; Dumas, M; Martin, F; Rey, D | 1 |
| Schwartz, PJ; Vanoli, E | 1 |
| Stewart, PA; Wladimiroff, JW | 1 |
| Bekhbudova, DA; Bochkareva, EV; Kokurina, EV; Ostrovskaia, TP; Urumbaev, RK | 1 |
| Agmon, J; Arditti, A; Kusniec, J; Lewin, RF; Sclarovsky, S; Strasberg, B | 1 |
| Bandieri, JD; Chiale, PA; Elizari, MV; Haedo, AH; Lázzari, JO; Rosenbaum, MB | 1 |
| Chowdry, IH; Gomes, JA; Hariman, RJ; Kang, PS | 1 |
| Koren, G | 1 |
| Bonso, A; D'Este, D; Delise, P; Di Pede, F; Piccolo, E; Raviele, A | 1 |
| Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F | 1 |
| Duperron, L; Gauthier, R; Grignon, A; LeLorier, J; Lemay, M; Rey, E | 1 |
| Opie, LH | 1 |
| Lawrie, TD | 1 |
| Aloisi, B; Brancati, B; Liistro, M; Mazzaglia, G; Negro, R; Russo, L | 1 |
| Peters, RW | 1 |
| Camin, G; Disertori, M; Fiorentini, F; Furlanello, F; Guareneiro, M; Inama, G; Nicasi, L | 1 |
| Barsotti, GP; Danisi, M; Giorgetti, C; Pratali, MC; Viti, V | 1 |
| DiBianco, R; Fletcher, RD; Gottdiener, JS | 1 |
| Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
| Hillis, WS; Whiting, B | 1 |
| Prystowsky, EN | 1 |
| Bowles, BJ; Healy, TE; Pleuvry, BJ | 1 |
| Ali, C; Holt, DW; Volans, GN | 1 |
| Somberg, JC | 1 |
| Jahrmärker, H; Theisen, K | 1 |
| Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
| Mohiuddin, SM; Ross, WB | 1 |
| Ducouret, P; Gargouïl, YM; Moreau, M; Néliat, G | 2 |
| Motté, G | 1 |
| Ikeda, N; Josephson, MA; Kannan, R; Nademanee, K; Singh, BN; Venkatesh, N | 1 |
| Hess, DS; Scheinman, MM | 1 |
| Bertrand, ME; Lablanche, JM; Thieuleux, FA; Tilmant, PY | 1 |
| Rosen, MR; Wit, AL | 1 |
| Campbell, RM; Dick, M | 1 |
| Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F | 1 |
| Goodwin, JF; Oakley, CM | 1 |
| Halawa, B | 1 |
| Golitsyn, SP; Grosu, AA; Smetnev, AS; Sokolov, SF | 1 |
| Benchimol, A; Desser, KB | 1 |
| Hess, D | 1 |
| Nademanee, K; Singh, BN | 1 |
| Harrison, DC; Kates, RE; Keefe, DL | 1 |
| Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
| Alegría, E; Arcas, R; Barba, J; Llorens, R; Malpartida, F; Martín Trenor, A | 1 |
| Barzilay, Z; Frand, M; Shahar, E; Shem-Tov, AA; Shohet, I | 1 |
| Zeng, GY | 1 |
| Goodwin, JF; McKenna, WJ | 1 |
| Lukoshevichiute, AI; Reĭngardene, DI | 1 |
| Araujo, LI; Crosatto, JR; Dyszel, E; Girotti, LA; Kaski, JC; Messuti, H; Rivas, CA; Rosenbaum, MB; Vetulli, HD | 1 |
| Flaker, GC; Munuswamy, K | 1 |
| Goodwin, JF; Harris, L; Krikler, DM; McKenna, WJ; Oakley, C; Perez, G | 1 |
| Camous, JP; Crenesse, D; Guiran, JB; Lapalus, P; Varenne, A | 1 |
| Campbell, RW | 1 |
| Bertoni, PD; Di Michele, R; Tosetto, C | 1 |
| Dreifus, LS; Kaplinsky, E; Kmetzo, JJ; Michelson, EL; Naito, M | 1 |
| Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
| Desnos, M; Guérot, C; Hagège, A | 1 |
| Ling, V; Shapiro, AB | 1 |
| Albarrán, A; Alonso, M; Andreu, J; Tascón, JC | 1 |
| Decrinis, M; Kasper, K; Schulze-Bauer, C; Stark, G; Stark, U; Tritthart, HA | 2 |
| Materukhin, AN; Molodan, AV; Osaulenko, VV; Salgalov, AV | 1 |
| Just, H; Meinertz, T; Zehender, M | 1 |
| Chalmers, JP; McRitchie, RJ; Roberts-Thomson, P; Twidale, N | 1 |
| Coolen, L; Demedts, MG; Deneffe, GJ; Lacquet, LM; Malysse, I; Van Mieghem, W | 1 |
| Lüderitz, B; Manz, M | 1 |
| Hayashi, Y; Kamibayashi, T; Kawabata, K; Sumikawa, K; Takada, K; Yamatodani, A; Yoshiya, I | 1 |
| Cordes, HP; Pajeva, IK; Seydel, JK; Wiese, M | 1 |
| Demedts, M; Demuynck, K; Deneffe, G; Lacquet, L; Tits, G; Tjandra-Maga, T; Van Mieghem, W | 1 |
| Chang, MS; Chen, SA; Cheng, CC; Chiang, CE; Chiou, CW; Lee, SH; Tai, CT; Ueng, KC; Wen, ZC | 1 |
| Dukhanin, AS; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Sergeev, PV | 1 |
| Bartashevich, VV; Galenko-Iaroshevskiĭ, PA; Galygo, DS; Khankoeva, AI; Melkumova, ER; Turovaia, AIu; Uvarov, AV | 1 |
| Jacobsen, EA; Mortensen, E; Pedersen, HK; Refsum, H | 1 |
| Chang, MS; Chen, SA; Ding, YA; Feng, AN; Kuo, BI; Lee, SH; Tai, CT; Yu, WC | 1 |
| Bartashevich, VV; Boldin, VB; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Popov, PB; Sirotenko, DV; Uvarov, AV | 1 |
| D'Andrea, A; Ducceschi, V; Iacono, A; Liccardo, B; Santangelo, L; Sarubbi, B | 1 |
| Sharland, GK; Simpson, JM | 1 |
| Estevez, MD; Schramm, U; Wolf, A | 1 |
| Dell'Orfano, JT; Luck, JC; Naccarelli, GV; Patel, HM; Wolbrette, DL | 1 |
| Trohman, RG | 1 |
| Landwojtowicz, E; Seelig, A | 1 |
| Bagliani, G; Colella, A; Costoli, A; Franchi, F; Gensini, GF; Lazzeri, C; Michelucci, A; Padeletti, L; Pieragnoli, P; Sabini, A; Zipoli, R | 1 |
| Dai, DZ; Kong, RZ; Li, HT; Wang, YQ | 1 |
| Kang, W; Weiss, M | 2 |
| Dicandia, CD; Favale, S; Fino, F; Nacci, F; Pappone, C; Resta, F | 1 |
| Alfano, F; Campana, A; Canciello, M; De Fabrizio, G; De Matteis, C; De Pasquale, M; De Simone, A; Di Mauro, M; Manzo, M; Sabino, L; Stabile, G; Turco, P; Vitale, DF | 1 |
| Aybek, T; Dzemali, O; Moritz, A; Scherer, M; Wimmer-Greinecker, G | 1 |
| Chi, CS; Fu, YC; Jan, SL; Wang, JD | 1 |
| Anisimova, VA; Kirillov, OV; Petrov, VI; Spasov, AA | 1 |
| Kohno, Y; Suzuki, A; Yamamoto, T | 1 |
| Moyssakis, I; Papadopoulos, DP; Votteas, VE | 1 |
| Bass, EB; Tamariz, LJ | 1 |
| Blagova, OV; Bogdanova, EA; Nedostup, AV; Platonova, AA | 1 |
| Crijns, HJ; Merckx, KL; Tieleman, RG | 1 |
| Freestone, B; Kamath, S; Lip, G | 1 |
| Freestone, B; Lip, GY | 2 |
| Rosovski, U; Viskin, S | 1 |
| Hajdú, J; Papp, Z; Pete, B | 1 |
| Behrens, S; Kamke, W; Stahn, A; Sticherling, C; Zabel, M | 1 |
| Galenko-Yaroshevskii, PA; Kade, AKh; Khvitiya, NG; Kiguradze, MI; Tatulashvili, DR; Turovaya, AY; Uvarov, AE | 1 |
| Lip, GY | 1 |
| Hamlin, RL; Keene, BW; Kijtawornrat, A; Nishijima, Y; Roche, BM | 1 |
| Arakaki, T; Isomoto, S; Kawakami, A; Ono, K; Yamashita, S; Yano, K | 1 |
| Abdelrahman, O; Sermsappasuk, P; Weiss, M | 1 |
| Cai, Y; Jia, J; Li, S; Liu, G; Liu, Y; Pan, C; Ren, J; Yu, C | 1 |
| Sahney, S | 1 |
| Altamura, L; De Paulis, S; Niccoli, G; Possati, GF; Pragliola, C; Siviglia, M | 1 |
| Basso, C; Bobbo, F; Iliceto, S; Maron, BJ; Melacini, P; Thiene, G; Tokajuk, B; Zucchetto, M | 1 |
| Cui, WY; Luo, RH; Wang, H; Wang, JA; Wang, SP | 1 |
| Bett, GC; Chen, J; Huang, C; Jiang, X; Li, X; Rasmusson, RL; Wang, S; Xu, L | 1 |
| Ding, AW; Duan, JA; Lü, GH; Lu, WJ; Ma, HY; You, FQ; Zhou, J | 1 |
| Drożdż, J; Filipiak, KJ; Grajek, S; Kasprzak, JD; Opolski, G; Rynkiewicz, A; Stępińska, J; Tykarski, A; Wożakowska Kapłon, B | 1 |
| Hu, ZY; Zhao, Y | 1 |
| Atenchong, N; Becker, S; Ciesek, S; Dahlmann, F; David, S; Gehring, G; Manns, MP; Mittler, E; Pöhlmann, S; Rohrmann, K; von Hahn, T; Vondran, FW | 1 |
| Chen, L; Liang, D; Lin, J; Lin, Y; Qi, G; Tian, W; Wang, X | 1 |
| Allen, LB; Anderson, A; Genaro-Mattos, TC; Korade, Z; Mirnics, K; Porter, NA | 1 |
| Frediani, L; Gurbel, PA; Kubica, J; Musci, RL; Navarese, EP | 1 |
| Duan, X; Gui, Y; Jia, J; Li, S; Liu, CC; Liu, G; Lu, Y; Zhang, M | 1 |
| Epanchintsev, TI; Panfilov, AV; Pravdin, SF | 1 |
| Andreotti, F; Brouwer, MA; Bukowski, P; Conte, M; Gajda, J; Gajda, R; Jasiewicz, M; Kubica, A; Kubica, J; La Torre, G; Lackowski, P; Michalski, P; Navarese, EP; Nowicka, M; Omyła, M; Orsini, N; Piasecki, M; Pietrzykowski, Ł; Pinkas, J; Podhajski, P; Radziwanowski, A; Szymański, P; Urbanowicz, I | 1 |
| Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S | 1 |
37 review(s) available for amiodarone and verapamil
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Lidocaine; Procainamide; Quinidine; Verapamil | 1977 |
New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Disopyramide; Electrophysiology; Humans; Mexiletine; Morpholines; Phenothiazines; Verapamil | 1978 |
[Medical therapy of chronic coronary insufficiency].
Topics: Amiodarone; Angina Pectoris; Chronic Disease; Coronary Disease; Digitalis Glycosides; Humans; Lidoflazine; Oxyfedrine; Perhexiline; Practolol; Prenylamine; Verapamil | 1978 |
[Mechanisms of interactions of anti-arrhythmia agents during their combined use].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Potassium; Procainamide; Propranolol; Quinidine; Verapamil | 1991 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Rationale of combination antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Digitalis Glycosides; Drug Therapy, Combination; Humans; Mexiletine; Myocardial Infarction; Quinidine; Tachycardia; Verapamil | 1985 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Comparison of newer antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Disopyramide; Humans; Mexiletine; Tocainide; Verapamil | 1980 |
[Long-term drug therapy of reciprocating supraventricular tachycardia: re-examination of a selected series of cases, using computerized programs].
Topics: Acebutolol; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Child; Computers; Digoxin; Humans; Medigoxin; Middle Aged; Oxprenolol; Propafenone; Propiophenones; Sotalol; Tachycardia; Verapamil | 1980 |
Effects of antiarrhythmic agents on cardiac function.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Dogs; Encainide; Hemodynamics; Humans; Myocardial Contraction; Quinidine; Verapamil | 1982 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
The electrophysiology and pharmacology of verapamil, flecainide, and amiodarone: correlations with clinical effects and antiarrhythmic actions.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Drug Interactions; Flecainide; Heart; Hemodynamics; Humans; In Vitro Techniques; Myocardial Contraction; Piperidines; Verapamil | 1984 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half-Life; Humans; Hypertension; Lidocaine; Metoprolol; Nadolol; Nifedipine; Propanolamines; Propranolol; Tocainide; Verapamil | 1983 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of newer antiarrhythmic drugs.
Topics: Acebutolol; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Atenolol; Benzeneacetamides; Disopyramide; Dogs; Hemodynamics; Humans; Mexiletine; Piperidines; Tocainide; Verapamil | 1980 |
New antiarrhythmic drugs: their place in therapy.
Topics: Action Potentials; Ajmaline; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Tosylate; Disopyramide; Encainide; Hemodynamics; Humans; Kinetics; Moricizine; Morpholines; Phenothiazines; Piperidines; Verapamil | 1981 |
[Treatment of coronary arterial spasm].
Topics: Amiodarone; Coronary Vasospasm; Denervation; Diltiazem; Humans; Isosorbide Dinitrate; Myocardial Revascularization; Nifedipine; Nitroglycerin; Phenoxybenzamine; Phentolamine; Reserpine; Verapamil | 1982 |
The natural history of hypertrophic cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Death, Sudden; Humans; Nifedipine; Prognosis; Propranolol; Verapamil | 1981 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Myocardial Infarction; Procainamide; Quinidine; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
[Early surgical treatment of symptomatic hypertrophic obstructive myocardiopathy. Arguments against].
Topics: Adrenergic beta-Antagonists; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Diuretics; Echocardiography, Doppler; Humans; Mitral Valve Insufficiency; Prognosis; Time Factors; Verapamil | 1995 |
Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Disopyramide; Flecainide; Humans; Imidazoles; Pre-Excitation Syndromes; Propafenone; Quinidine; Sotalol; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Verapamil | 1993 |
Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Digoxin; Electric Countershock; Flecainide; Humans; Procainamide; Quinidine; Verapamil | 1998 |
Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy.
Topics: Algorithms; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Echocardiography, Transesophageal; Electric Countershock; Flecainide; Humans; Procainamide; Propafenone; Quinidine; Sotalol; Verapamil | 2000 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome | 2000 |
Pharmacological rate control of atrial fibrillation.
Topics: Amiodarone; Atenolol; Atrial Fibrillation; Cardiotonic Agents; Digoxin; Diltiazem; Heart Rate; Humans; Metoprolol; Randomized Controlled Trials as Topic; Verapamil | 2004 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Humans; Timolol; Verapamil | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Timolol; Verapamil | 2003 |
Atrial fibrillation (acute).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2004 |
Atrial fibrillation (recent onset).
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Flecainide; Humans; Propafenone; Verapamil | 2005 |
A review of calcium channel antagonists in the treatment of pediatric hypertension.
Topics: Amiodarone; Calcium Channel Blockers; Child; Felodipine; Humans; Hypertension; Isradipine; Nicardipine; Nifedipine; Verapamil | 2006 |
Ion channel inhibition against COVID-19: A novel target for clinical investigation.
Topics: Amiodarone; Communicable Disease Control; Coronavirus Infections; COVID-19; Female; Humans; Ion Channels; Male; Needs Assessment; Pandemics; Pneumonia, Viral; Poland; Severe Acute Respiratory Syndrome; Severity of Illness Index; Verapamil; Viral Proteins; World Health Organization | 2020 |
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil | 2023 |
13 trial(s) available for amiodarone and verapamil
| Article | Year |
|---|---|
[Prospective course of therapy arresting attacks of atrial fibrillation in patients with preexcitation syndromes].
Topics: Adult; Aged; Aged, 80 and over; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Female; Humans; Male; Mexiletine; Middle Aged; Moricizine; Pre-Excitation Syndromes; Procainamide; Propranolol; Quinidine; Time Factors; Verapamil | 1992 |
Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation: results of a comparative study and a 2-year follow-up.
Topics: Amiodarone; Atrial Fibrillation; Chronic Disease; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Diseases; Humans; Male; Middle Aged; Prospective Studies; Quinidine; Treatment Outcome; Verapamil | 1992 |
Intravenous amiodarone versus verapamil for acute conversion of paroxysmal atrial fibrillation to sinus rhythm.
Topics: Aged; Amiodarone; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Randomized Controlled Trials as Topic; Single-Blind Method; Verapamil | 1990 |
Interatrial conduction block with retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmias: influence of preventive antiarrhythmic treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Block; Humans; Male; Middle Aged; Quinidine; Tachycardia, Supraventricular; Verapamil | 1989 |
Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells.
Topics: Adenocarcinoma; Amiodarone; Animals; Antibiotics, Antineoplastic; Cell Line; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Humans; Rats; Verapamil | 1987 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
[Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Topics: Aged; Amiodarone; Atrial Fibrillation; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Humans; Long-Term Care; Male; Middle Aged; Prospective Studies; Quinidine; Treatment Outcome; Verapamil | 1994 |
Amiodarone and the development of ARDS after lung surgery.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Humans; Incidence; Middle Aged; Pneumonectomy; Postoperative Complications; Prospective Studies; Respiratory Distress Syndrome; Retrospective Studies; Verapamil | 1994 |
Verapamil as prophylactic treatment for atrial fibrillation after lung operations.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Humans; Hypotension; Incidence; Middle Aged; Pneumonectomy; Postoperative Complications; Prospective Studies; Respiratory Distress Syndrome; Verapamil | 1996 |
Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Electrophysiology; Female; Humans; Male; Middle Aged; Pacemaker, Artificial; Procainamide; Propafenone; Propranolol; Sotalol; Tachycardia, Supraventricular; Verapamil | 1998 |
VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Disease-Free Survival; Drug Therapy, Combination; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Verapamil | 2003 |
Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Electric Countershock; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Recurrence; Verapamil | 2005 |
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Topics: Amiodarone; C-Reactive Protein; Carbidopa; COVID-19; Drug Combinations; Humans; Ion Channels; Levodopa; SARS-CoV-2; Verapamil | 2022 |
153 other study(ies) available for amiodarone and verapamil
| Article | Year |
|---|---|
Synthesis and activity against multidrug resistance in Chinese hamster ovary cells of new acridone-4-carboxamides.
Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; CHO Cells; Cricetinae; Cricetulus; Drug Resistance, Multiple; Mice; Structure-Activity Relationship | 1995 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Leukemia P388; Linear Models; Mice; Models, Biological; Models, Molecular; Monte Carlo Method; Tumor Cells, Cultured | 2000 |
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
Topics: Amino Acid Sequence; Animals; Base Sequence; Cloning, Molecular; COS Cells; DNA; Heart Block; Heart Diseases; Humans; Mice; Molecular Sequence Data; Potassium Channels; Potassium Channels, Voltage-Gated; Shaker Superfamily of Potassium Channels; Trinucleotide Repeats | 2002 |
Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis).
Topics: Adenosine Triphosphatases; Algorithms; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Binding, Competitive; Caco-2 Cells; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Humans; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rhodamine 123; Stereoisomerism; Verapamil; Vinblastine | 2002 |
Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods.
Topics: Cation Transport Proteins; Databases, Factual; Discriminant Analysis; Ether-A-Go-Go Potassium Channels; Holography; Linear Models; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quantitative Structure-Activity Relationship | 2003 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Fluoresceins; Fluorescent Dyes; Humans; Models, Molecular; Multivariate Analysis; Permeability; Quantitative Structure-Activity Relationship | 2005 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results | 2006 |
Small molecule regulators of autophagy identified by an image-based high-throughput screen.
Topics: Autophagy; Calcium Channel Blockers; Cell Line, Tumor; Drug Evaluation, Preclinical; Fluspirilene; Glioblastoma; Green Fluorescent Proteins; Humans; Intracellular Membranes; Loperamide; Microtubule-Associated Proteins; Mycotoxins; Peptides; Phagosomes; Phosphatidylinositol Phosphates; Pimozide; Protein Kinases; Recombinant Fusion Proteins; Sirolimus; Small Molecule Libraries; TOR Serine-Threonine Kinases; Trifluoperazine; Zinc Fingers | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Support vector machines classification of hERG liabilities based on atom types.
Topics: Animals; Arrhythmias, Cardiac; CHO Cells; Computer Simulation; Cricetinae; Cricetulus; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Chemical; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Predictive Value of Tests; ROC Curve | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Topics: Amiodarone; Astemizole; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Danazol; Drug Discovery; Drug Interactions; Enzyme Inhibitors; Humans; Hydroxylation; In Vitro Techniques; Methylation; Microsomes, Liver; Models, Biological; Molecular Structure; Substrate Specificity; Tandem Mass Spectrometry; Terfenadine | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
The treatment of supraventricular arrhythmias.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Digoxin; Disopyramide; Electric Countershock; Humans; Phenytoin; Procainamide; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1979 |
["Torsades de pointe" and reentry induced by anti-arrhythmia agents].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Flutter; Bretylium Compounds; Cardiac Complexes, Premature; Humans; Phenytoin; Prenylamine; Quinidine; Tachycardia; Ventricular Fibrillation; Verapamil | 1978 |
Dual-demand pacing for refractory atrioventricular re-entry tachycardia.
Topics: Adult; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Heart Ventricles; Humans; Male; Middle Aged; Pacemaker, Artificial; Propranolol; Sick Sinus Syndrome; Sinus of Valsalva; Tachycardia, Paroxysmal; Time Factors; Verapamil; Wolff-Parkinson-White Syndrome | 1979 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Child; Edrophonium; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Mexiletine; Recurrence; Tachycardia; Tocainide; Verapamil; Wolff-Parkinson-White Syndrome | 1978 |
[Prolongation of the effective refractory period on isolated guinea pig atria by some anti-arrhythmia agents: relevance in a comparison of their potentialities].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Lidocaine; Myocardial Contraction; Nifedipine; Verapamil | 1979 |
[Research on a rational basis for the origin and treatment of arrhythmia].
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium; Heart; Humans; Hyperthyroidism; Potassium; Propranolol; Quinidine; Rabbits; Refractory Period, Electrophysiological; Sodium; Verapamil | 1977 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
[The control of the atrio-ventricular reciprocating tachyarrhythmias. A preliminary electrophysiological study and comparison between amiodarone and verapamil (author's transl)].
Topics: Adult; Aged; Amiodarone; Benzofurans; Drug Evaluation; Female; Humans; Male; Middle Aged; Tachycardia, Paroxysmal; Verapamil; Wolff-Parkinson-White Syndrome | 1978 |
[Drug therapy of tachycardial arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digitalis Glycosides; Drug Therapy, Combination; Humans; Prenylamine; Tachycardia; Verapamil | 1976 |
[Experimental analysis of some cardiovascular effects of Verapamil].
Topics: Amiodarone; Animals; Anura; Arrhythmias, Cardiac; Blood Pressure; Calcium Chloride; Cardiovascular System; Coronary Circulation; Guinea Pigs; Platelet Aggregation; Rabbits; Rats; Sympatholytics; Sympathomimetics; Verapamil | 1975 |
Amiodarone and desethylamiodarone increase intrasynaptosomal free calcium through receptor mediated channel.
Topics: Amiodarone; Animals; Binding Sites; Calcium; Calcium Channels; Dizocilpine Maleate; Male; Microsomes; Mitochondria; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Synaptosomes; Tetrodotoxin; Verapamil | 1992 |
[Clinical effectiveness of cordarone in combination with other anti-arrhythmia agents in refractory atrial fibrillation and adverse effects of the drugs].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Drug Therapy, Combination; Humans; Middle Aged; Moricizine; Quinidine; Verapamil | 1992 |
Amiodarone, verapamil, and quinidine do not affect equilibrium binding of digoxin.
Topics: Amiodarone; Animals; Binding, Competitive; Digoxin; Dogs; Myocardium; Quinidine; Receptors, Drug; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Verapamil | 1990 |
[Treatment of ventricular arrhythmia resistant to sodium channel blockaders].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Resistance; Humans; Middle Aged; Phenothiazines; Sodium Channels; Tachycardia, Paroxysmal; Verapamil | 1991 |
FK-506 (fujimycin) reverses the multidrug resistance of tumor cells in vitro.
Topics: Amiodarone; Animals; Antibiotics, Antineoplastic; Cyclosporine; Doxorubicin; Drug Resistance; Leukemia P388; Tacrolimus; Tumor Cells, Cultured; Verapamil; Vincristine | 1991 |
Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative.
Topics: Amiodarone; Animals; Cyclosporins; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Flow Cytometry; Leukemia, Experimental; Leukemia, Myeloid; Microscopy, Fluorescence; Quinacrine; Quinidine; Tumor Cells, Cultured; Verapamil | 1991 |
Arrhythmogenic effects of antiarrhythmic drugs.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Risk Factors; Sotalol; Tachycardia; Verapamil | 1990 |
Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Barium; Calcium Channels; Dogs; Female; Heart Conduction System; Isoproterenol; Male; Membrane Potentials; Purkinje Fibers; Quinidine; Tachycardia; Verapamil | 1990 |
The inhibitory actions of amiodarone on rested-state contraction in isolated guinea-pig ventricular muscle.
Topics: Amiodarone; Animals; Caffeine; Female; Guinea Pigs; In Vitro Techniques; Male; Microelectrodes; Myocardial Contraction; Papillary Muscles; Verapamil | 1990 |
Cytotoxic interactions of cardioactive cationic amphiphilic compounds in primary rat hepatocytes in culture.
Topics: Amiodarone; Animals; Atenolol; Biomarkers; Cardiotonic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; L-Lactate Dehydrogenase; Liver; Male; Microscopy, Electron; Microscopy, Electron, Scanning; Procainamide; Propranolol; Rats; Rats, Inbred Strains; Sotalol; Verapamil | 1990 |
Increased cytotoxicity of nanoparticle-carried Adriamycin in vitro and potentiation by verapamil and amiodarone.
Topics: Amiodarone; Animals; Cricetinae; Cricetulus; Cyanoacrylates; Dactinomycin; Doxorubicin; Drug Carriers; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Protein Biosynthesis; Tumor Cells, Cultured; Verapamil | 1989 |
[Supraventricular tachyarrhythmia of recent onset in the absence of documented cardiac pathology: different therapeutic approaches].
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Female; Flecainide; Humans; Male; Middle Aged; Retrospective Studies; Tachycardia, Paroxysmal; Verapamil | 1989 |
[Idiopathic recurrent ventricular tachycardia: role of verapamil in its treatment].
Topics: Adolescent; Amiodarone; Electrocardiography; Heart Rate; Heart Ventricles; Humans; Middle Aged; Recurrence; Tachycardia; Verapamil | 1989 |
[Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiac Complexes, Premature; Cardiomyopathy, Hypertrophic; Death, Sudden; Drug Therapy, Combination; Electrocardiography; Heart Ventricles; Humans; Middle Aged; Propranolol; Risk; Tachycardia; Verapamil | 1985 |
Repeated intravascular treatment with amiodarone in a fetus with refractory supraventricular tachycardia and hydrops fetalis.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hydrops Fetalis; Injections, Intravenous; Pregnancy; Pregnancy Outcome; Recurrence; Tachycardia, Supraventricular; Umbilical Veins; Verapamil | 1989 |
Use of drugs in cardiac rehabilitation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Diltiazem; Drug Therapy, Combination; Electrocardiography; Exercise Test; Heart Diseases; Humans; Middle Aged; Nifedipine; Nitrates; Nitroglycerin; Physical Exertion; Verapamil | 1986 |
[Pharmacological cardioversion of paroxysmal atrial fibrillation: 3 methods compared].
Topics: Aged; Amiodarone; Atrial Fibrillation; Deslanoside; Drug Evaluation; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Methods; Middle Aged; Quinidine; Verapamil | 1987 |
Antiarrhythmic drugs and the modulation of autonomic control of heart rate in rabbits.
Topics: Adenosine; Amiodarone; Animals; Anti-Arrhythmia Agents; Bradycardia; Female; Heart Conduction System; Heart Rate; Male; Nadolol; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Receptors, Muscarinic; Sinoatrial Node; Sympathetic Nervous System; Vagus Nerve; Verapamil | 1986 |
His bundle tachycardia--arrhythmogenic and antiarrhythmic effects of therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle of His; Electrocardiography; Flecainide; Humans; Infant, Newborn; Male; Tachycardia; Verapamil | 1987 |
Unstable angina with tachycardia: clinical and therapeutic implications.
Topics: Aged; Amiodarone; Angina Pectoris; Angina, Unstable; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Propranolol; Prospective Studies; Tachycardia; Verapamil | 1988 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem; Lidocaine; Mexiletine; Nifedipine; Phenoxybenzamine; Prazosin; Propafenone; Propiophenones; Propranolol; Stellate Ganglion; Verapamil | 1986 |
Treatment of fetal cardiac arrhythmias.
Topics: Amiodarone; Arrhythmia, Sinus; Arrhythmias, Cardiac; Chromosome Aberrations; Chromosome Disorders; Diagnosis, Differential; Digoxin; Drug Therapy, Combination; Echocardiography; Edema, Cardiac; Female; Fetal Diseases; Fetal Growth Retardation; Fetal Heart; Gestational Age; Heart Rate; Humans; Karyotyping; Lung; Maternal-Fetal Exchange; Pregnancy; Procainamide; Prognosis; Propranolol; Quinidine; Ultrasonography; Vena Cava, Superior; Verapamil | 1985 |
[Characteristics of patients with ischemic heart disease under dispensary observation in a regional polyclinic and the evaluation of anti-angina therapy conducted under dispensary conditions].
Topics: Adult; Ambulatory Care; Amiodarone; Angina Pectoris; Coronary Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Isosorbide Dinitrate; Male; Nifedipine; Nitroglycerin; Propranolol; Time Factors; Vasodilator Agents; Verapamil | 1985 |
An unusual ventricular tachycardia responsive to verapamil.
Topics: Adult; Amiodarone; Bundle-Branch Block; Electrocardiography; Heart Ventricles; Humans; Lidocaine; Male; Tachycardia; Verapamil | 1986 |
Comparative antiarrhythmic efficacy of verapamil, 17-monochloracetylajmaline, mexiletine and amiodarone in patients with severe chagasic myocarditis: relation with the underlying arrhythmogenic mechanisms.
Topics: Adult; Ajmaline; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Chagas Cardiomyopathy; Female; Humans; Male; Mexiletine; Middle Aged; Placebos; Propylamines; Verapamil | 1986 |
Sustained symptomatic sinus node reentrant tachycardia: incidence, clinical significance, electrophysiologic observations and the effects of antiarrhythmic agents.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrophysiology; Humans; Male; Middle Aged; Ouabain; Propranolol; Sinoatrial Node; Tachycardia; Tachycardia, Paroxysmal; Time Factors; Verapamil | 1985 |
Interaction between digoxin and commonly coadministered drugs in children.
Topics: Amiodarone; Child, Preschool; Digoxin; Drug Interactions; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Nifedipine; Quinidine; Spironolactone; Verapamil | 1985 |
[Idiopathic ventricular tachycardia responsive to verapamil. Presentation of 3 cases and review of the literature].
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Bundle-Branch Block; Female; Humans; Male; Tachycardia; Verapamil | 1985 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocarditis; Myocardium; Pacemaker, Artificial; Tachycardia; Verapamil | 1985 |
Transplacental treatment of tachycardia-induced fetal heart failure with verapamil and amiodarone: a case report.
Topics: Adult; Amiodarone; Benzofurans; Female; Fetal Diseases; Fetal Heart; Heart Failure; Heart Rate; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Tachycardia; Verapamil | 1985 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
[Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks].
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Benzofurans; Drug Therapy, Combination; Humans; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
[Treatment of supraventricular tachycardia].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Digitalis Glycosides; Electrocardiography; Humans; Quinidine; Tachycardia; Verapamil | 1981 |
[Prospects for drug therapy in the rehabilitation of the cardiac patient].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Benzofurans; Heart Diseases; Humans; Male; Middle Aged; Verapamil | 1980 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
The effect on the rat isolated atria of amiodarone in the presence of either ouabain or verapamil.
Topics: Amiodarone; Animals; Benzofurans; Drug Interactions; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Ouabain; Rats; Rats, Inbred Strains; Verapamil | 1983 |
Management of cardiac drug overdose.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Disopyramide; Humans; Phenytoin; Poison Control Centers; Verapamil | 1984 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Antiarrhythmic therapy: new additions and future expectations.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Bretylium Tosylate; Disopyramide; Encainide; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1983 |
Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzofurans; Ferrets; Heart; In Vitro Techniques; Ion Channels; Membrane Potentials; Rana esculenta; Verapamil | 1982 |
[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamines; Electrolytes; Heart Conduction System; Humans; Ion Channels; Lidocaine; Prognosis; Quinidine; Verapamil | 1981 |
[Strategy of the treatment of vasospastic angina pectoris].
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Arteriosclerosis; Coronary Artery Bypass; Coronary Vasospasm; Diltiazem; Humans; Middle Aged; Nifedipine; Nitroglycerin; Radiography; Verapamil | 1983 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pacing, Artificial; Child; Child, Preschool; Electrocardiography; Humans; Infant; Modems; Pacemaker, Artificial; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1984 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart Defects, Congenital; Humans; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Medical and surgical treatment of hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathy, Hypertrophic; Child; Electric Countershock; Female; Heart Septum; Humans; Male; Middle Aged; Myocardial Contraction; Propranolol; Verapamil | 1983 |
[Interactions between digoxin and amiodarone (Cordarone), verapamil (Isoptin) and melsidomine (Corvatone)].
Topics: Adult; Amiodarone; Cardiotonic Agents; Coronary Disease; Digoxin; Drug Interactions; Humans; Male; Middle Aged; Molsidomine; Sydnones; Verapamil | 1983 |
[Method of evaluating antiarrhythmic therapy in patients with paroxysms of supraventricular tachycardia].
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Digoxin; Drug Evaluation; Electric Stimulation; Female; Humans; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Tachycardia, Paroxysmal; Verapamil | 1984 |
New drugs for treating cardiac arrhythmias.
Topics: Acebutolol; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Heart Ventricles; Humans; Mexiletine; Moricizine; Morpholines; Phenothiazines; Tocainide; Verapamil | 1981 |
Newer antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Tocainide; Verapamil | 1981 |
Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrioventricular Node; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1982 |
Electrophysiologic testing of antiarrhythmic agents.
Topics: Administration, Oral; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Vessels; Dogs; Electrophysiology; Encainide; Heart; Time Factors; Verapamil | 1982 |
Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Digoxin; Electrocardiography; Humans; Infant; Infant, Newborn; Tachycardia, Paroxysmal; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
[Clinical pharmacology of anti-arrhythmia agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Quinidine; Verapamil | 1983 |
Electrophysiological effects of butoprozine on isolated heart preparations. Comparison with amiodarone and verapamil.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Benzofurans; Ferrets; In Vitro Techniques; Membrane Potentials; Purkinje Fibers; Rana esculenta; Sheep; Verapamil | 1982 |
The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina.
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Coronary Vasospasm; Diagnosis, Differential; Electrocardiography; Female; Follow-Up Studies; Humans; Hyperventilation; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Phentolamine; Propranolol; Verapamil | 1982 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Mexiletine; Verapamil | 1982 |
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; Female; Humans; Male; Middle Aged; Verapamil | 1981 |
Effects in conscious dogs of ajmaline, propranolol, amiodarone and verapamil on right ventricular anodal strength-interval curves.
Topics: Ajmaline; Amiodarone; Animals; Anti-Arrhythmia Agents; Dogs; Myocardial Contraction; Propranolol; Verapamil | 1981 |
Antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Lidocaine; Quinidine; Verapamil | 1981 |
[Conversion of recent atrial fibrillation to sinus rhythm. Predictive value of the clinical and echocardiographic parameters].
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Echocardiography; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Quinidine; Verapamil | 1981 |
Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Vessels; Dogs; Lidocaine; Ligation; Perfusion; Procainamide; Ventricular Fibrillation; Verapamil | 1981 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
[Hypertrophic cardiomyopathy: place and limitations of medical therapy].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bradycardia; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; Female; Humans; Male; Verapamil | 1995 |
Reconstitution of drug transport by purified P-glycoprotein.
Topics: Adenosine Triphosphatases; Amiodarone; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Biological Transport; Cell-Free System; Cricetinae; DNA; Fluorescent Dyes; Glucosides; Hydrogen-Ion Concentration; Lipids; Liposomes; Particle Size; Protein Conformation; Verapamil | 1995 |
Comparison of the frequency-dependent effects on the atrioventricular node of verapamil, amiodarone, digoxin, and diltiazem in isolated guinea pig hearts.
Topics: Amiodarone; Animals; Atrioventricular Node; Cardiac Pacing, Artificial; Computer Simulation; Digoxin; Diltiazem; Electric Stimulation; Electrocardiography; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Male; Verapamil | 1995 |
[The preoperative drug correction of disorders in myocardial functional reserve in patients with ischemic heart disease].
Topics: Adult; Amiodarone; Combined Modality Therapy; Coronary Artery Bypass; Drug Therapy, Combination; Heart; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Nifedipine; Preoperative Care; Verapamil | 1994 |
Comparative haemodynamic effects of verapamil, flecainide, amiodarone and sotalol in the conscious rabbit.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Autonomic Nerve Block; Autonomic Nervous System; Cardiac Output; Cardiac Pacing, Artificial; Consciousness; Flecainide; Heart; Heart Atria; Heart Rate; Hemodynamics; Male; Rabbits; Sotalol; Verapamil | 1994 |
Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
Topics: Amiodarone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Flecainide; Halothane; Isoflurane; Lidocaine; Male; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Verapamil | 1993 |
Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Breast Neoplasms; Calorimetry, Differential Scanning; Dopamine Antagonists; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flupenthixol; Heterocyclic Compounds; Humans; Leukemia P388; Magnetic Resonance Spectroscopy; Membranes, Artificial; Mice; Phosphatidylcholines; Phosphatidylserines; Verapamil | 1996 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardiac Catheterization; Cardiac Pacing, Artificial; Disease Progression; Electrocardiography; Female; Follow-Up Studies; Humans; Isoproterenol; Life Tables; Male; Middle Aged; Procainamide; Proportional Hazards Models; Remission, Spontaneous; Tachycardia, Atrioventricular Nodal Reentry; Verapamil; Wolff-Parkinson-White Syndrome | 1996 |
[Mechanism of action of befol on calcium metabolism in cardiomyocytes using the fluorescent probe fura-2].
Topics: Amiodarone; Animals; Benzamides; Caffeine; Calcium; Fura-2; Heart; In Vitro Techniques; Ion Transport; Morpholines; Myocardium; Rats; Verapamil | 1996 |
How to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrioventricular Node; Cardiac Pacing, Artificial; Digoxin; Diltiazem; Electrocardiography; Female; Fourier Analysis; Guinea Pigs; Heart Rate; Male; Signal Processing, Computer-Assisted; Verapamil | 1996 |
[Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cats; Histamine H1 Antagonists; Indoles; Myocardial Infarction; Myocardial Ischemia; Myocardium; Necrosis; Propranolol; Verapamil | 1996 |
Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Catheterization; Contrast Media; Coronary Angiography; Coronary Vessels; Dogs; Heart Conduction System; Injections, Intra-Arterial; Iohexol; Lidocaine; Premedication; Propanolamines; Propranolol; Ventricular Fibrillation; Verapamil | 1995 |
[Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzamides; Benzimidazoles; Cardiotonic Agents; Dibenzazepines; Drug Antagonism; Electrocardiography; Lidocaine; Male; Morpholines; Procainamide; Propranolol; Rats; Rats, Wistar; Succinates; Tryptophan; Verapamil | 1998 |
Fetal tachycardias: management and outcome of 127 consecutive cases.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Chi-Square Distribution; Digoxin; Female; Fetal Distress; Fetus; Flecainide; Humans; Hydrops Fetalis; Maternal-Fetal Exchange; Pregnancy; Retrospective Studies; Statistics, Nonparametric; Verapamil | 1998 |
Effect of PSC 833, verapamil and amiodarone on adriamycin toxicity in cultured rat cardiomyocytes.
Topics: Actins; Amiodarone; Animals; Anti-Arrhythmia Agents; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cells, Cultured; Creatine Kinase; Cyclosporins; Doxorubicin; Heart; Image Processing, Computer-Assisted; Immunohistochemistry; Isoenzymes; Myocardial Contraction; Myocardium; Rats; Rats, Wistar; Verapamil | 2000 |
Structure-activity relationship of P-glycoprotein substrates and modifiers.
Topics: Adenosine Triphosphatases; Amiodarone; Amitriptyline; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CHO Cells; Colchicine; Cricetinae; Cyclosporine; Daunorubicin; Diltiazem; Kinetics; Micelles; Progesterone; Propranolol; Structure-Activity Relationship; Verapamil; Vinblastine | 2000 |
Altered values of heart rate variability in patients with relapse of atrial fibrillation during the first week after electrical cardioversion: preliminary data.
Topics: Aged; Amiodarone; Atrial Fibrillation; Circadian Rhythm; Electric Countershock; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Observer Variation; Predictive Value of Tests; Propafenone; Recurrence; Sensitivity and Specificity; Time Factors; Vasodilator Agents; Verapamil | 2001 |
Frequency dependent prolongation of effective refractory period by a complex class III antiarrhythmic agent CPU-86017.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Berberine; Calcium Channel Blockers; Female; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Papillary Muscles; Phenethylamines; Piperidines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides; Verapamil | 2001 |
P-glycoprotein inhibitors enhance saturable uptake of idarubicin in rat heart: pharmacokinetic/pharmacodynamic modeling.
Topics: Algorithms; Amiodarone; Animals; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Depression, Chemical; Enzyme Inhibitors; Heart; Heart Rate; Idarubicin; In Vitro Techniques; Kinetics; Male; Models, Biological; Myocardium; Nonlinear Dynamics; Rats; Rats, Sprague-Dawley; Verapamil | 2002 |
Modeling the metabolism of idarubicin to idarubicinol in rat heart: effect of rutin and phenobarbital.
Topics: Amiodarone; Animals; Antineoplastic Agents; Daunorubicin; Drug Design; Excitatory Amino Acid Antagonists; Heart; Idarubicin; Kinetics; Male; Phenobarbital; Rats; Rats, Sprague-Dawley; Rutin; Time Factors; Vasodilator Agents; Verapamil | 2003 |
Sudden death due to atrial fibrillation in hypertrophic cardiomyopathy: a predictable event in a young patient.
Topics: Adult; Amiodarone; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Humans; Verapamil | 2003 |
Impact of left atrial size reduction on chronic atrial fibrillation in mitral valve surgery.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiopulmonary Bypass; Chronic Disease; Cohort Studies; Digitoxin; Echocardiography; Electric Countershock; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve; Postoperative Complications; Sotalol; Survival Analysis; Treatment Outcome; Verapamil | 2003 |
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography; Female; Humans; Infant; Lidocaine; Propranolol; Tachycardia, Ventricular; Verapamil | 2003 |
[The development and clinical testing of antiarrhythmia drugs of a new chemical class].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzimidazoles; Calcium Channel Blockers; Clinical Trials as Topic; Electrocardiography; Female; Humans; Male; Middle Aged; Procainamide; Verapamil | 2003 |
High-throughput screening for the assessment of time-dependent inhibitions of new drug candidates on recombinant CYP2D6 and CYP3A4 using a single concentration method.
Topics: Amiodarone; Animals; Baculoviridae; Binding, Competitive; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Enzyme Inhibitors; Fluorescence; Humans; Inhibitory Concentration 50; Ketoconazole; Miconazole; Midazolam; Propafenone; Quinolines; Recombinant Proteins; Troleandomycin; Verapamil | 2004 |
Polyarteritis nodosa and hypertrophic obstructive cardiomyopathy. A true association?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Cyclophosphamide; Drug Therapy, Combination; Echocardiography; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Polyarteritis Nodosa; Treatment Outcome; Verapamil | 2004 |
[Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Digoxin; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Periodicity; Sotalol; Ventricular Premature Complexes; Verapamil | 2004 |
Cardioversion threshold, IRAF and beyond.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Verapamil | 2004 |
The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
Topics: Acetanilides; Amiodarone; Anti-Arrhythmia Agents; Humans; Piperazines; Potassium Channel Blockers; Ranolazine; Research Design; Torsades de Pointes; Verapamil | 2005 |
[Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
Topics: Amiodarone; Anti-Arrhythmia Agents; Digoxin; Electric Countershock; Female; Fetal Diseases; Follow-Up Studies; Gestational Age; Hemodynamics; Humans; Male; Retrospective Studies; Tachycardia; Tachycardia, Supraventricular; Verapamil | 2004 |
Effects of verapamil and amiodarone on sympathoadrenal system and balance of excitatory and inhibitory amino acids in rat medulla oblongata.
Topics: Adrenal Glands; Amiodarone; Animals; Calcium Channel Blockers; Dopamine; Epinephrine; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Levodopa; Male; Medulla Oblongata; Microinjections; Norepinephrine; Potassium Channel Blockers; Random Allocation; Rats; Rats, Inbred Strains; Serotonin; Sympathetic Nervous System; Verapamil | 2005 |
Use of a failing rabbit heart as a model to predict torsadogenicity.
Topics: Amiodarone; Animals; Cardiac Output, Low; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Models, Animal; Phenethylamines; Quaternary Ammonium Compounds; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Verapamil | 2006 |
Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Caspases; Cell Line; Clone Cells; Diploidy; DNA Fragmentation; Dose-Response Relationship, Drug; Lidocaine; Membrane Potentials; Mitochondrial Membranes; Propranolol; Pyrimidinones; Signal Transduction; Time Factors; Verapamil | 2006 |
Modeling cardiac uptake and negative inotropic response of verapamil in rat heart: effect of amiodarone.
Topics: Algorithms; Amiodarone; Animals; Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Data Interpretation, Statistical; Heart; In Vitro Techniques; Male; Models, Statistical; Myocardium; Rats; Rats, Wistar; Verapamil | 2007 |
Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography--tandem mass spectrometry.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, Liquid; Diltiazem; Humans; Metoprolol; Mexiletine; Molecular Structure; Propanolamines; Propranolol; Reproducibility of Results; Sotalol; Tandem Mass Spectrometry; Verapamil | 2007 |
Postoperative coronary artery spasm complicating aortic valve replacement: implications for identification and treatment.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aortic Valve Insufficiency; Coronary Angiography; Coronary Vasospasm; Drug Therapy, Combination; Heart Valve Prosthesis; Humans; Injections, Intra-Arterial; Male; Nitrates; Vasodilator Agents; Verapamil | 2007 |
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Hypertrophic; Child; Child, Preschool; Death, Sudden, Cardiac; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Sotalol; Verapamil | 2007 |
Potassium channel currents in rat mesenchymal stem cells and their possible roles in cell proliferation.
Topics: Amiodarone; Animals; Cell Cycle; Cell Proliferation; Cell Survival; Cells, Cultured; Male; Membrane Potentials; Mesenchymal Stem Cells; Nifedipine; Potassium Channel Blockers; Potassium Channels; Protein Subunits; Rats; Rats, Wistar; RNA, Messenger; Verapamil | 2008 |
Effect of amiodarone on Kv1.4 channel C-type inactivation: comparison of its effects with those induced by propafenone and verapamil.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Female; Kv1.4 Potassium Channel; Oocytes; Patch-Clamp Techniques; Propafenone; Verapamil; Xenopus laevis; Xenopus Proteins | 2008 |
[Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bufanolides; Electrocardiography; Female; Heart Rate; In Vitro Techniques; Lethal Dose 50; Lidocaine; Male; Mice; Phenytoin; Propranolol; Verapamil | 2011 |
[Optimum heart rate - the current goal of cardiovascular therapy. Position statement of the Polish Cardiac Society Working Group on Cardiovascular Drug Therapy].
Topics: Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Digoxin; Diltiazem; Heart Diseases; Heart Rate; Humans; Hypertension; Ivabradine; Verapamil | 2012 |
Physiologically based pharmacokinetic modelling and in vivo [I]/K(i) accurately predict P-glycoprotein-mediated drug-drug interactions with dabigatran etexilate.
Topics: Amiodarone; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; beta-Alanine; Clarithromycin; Dabigatran; Digoxin; Dronedarone; Drug Interactions; Humans; Models, Biological; Pyridines; Quinidine; Verapamil | 2014 |
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.
Topics: Adrenergic Antagonists; Amiodarone; Animals; Arenaviruses, New World; Bunyaviridae; Calcium Channel Blockers; Cell Line; Dronedarone; Ebolavirus; Humans; Lassa virus; Marburgvirus; Potassium Channel Blockers; Sodium Channel Blockers; Verapamil; Vesicular stomatitis Indiana virus; Virus Internalization | 2014 |
Treatment with verapamil for restoration of sinus rhythm in atrial fibrillation with rapid ventricular response: A case report.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Female; Humans; Propafenone; Verapamil | 2019 |
Amiodarone Alters Cholesterol Biosynthesis through Tissue-Dependent Inhibition of Emopamil Binding Protein and Dehydrocholesterol Reductase 24.
Topics: Amiodarone; Carrier Proteins; Cholesterol; Dehydrocholesterols; Desmosterol; Humans; Nerve Tissue Proteins; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Verapamil | 2020 |
Direct analysis in real time-mass spectrometry for rapid quantification of five anti-arrhythmic drugs in human serum: application to therapeutic drug monitoring.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Computer Systems; Diltiazem; Drug Monitoring; Humans; Metoprolol; Pharmaceutical Preparations; Propafenone; Tandem Mass Spectrometry; Verapamil | 2020 |
Overdrive pacing of spiral waves in a model of human ventricular tissue.
Topics: Action Potentials; Amiodarone; Arrhythmias, Cardiac; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Models, Cardiovascular; Ventricular Fibrillation; Verapamil | 2020 |